Abstract
Melanoma is the most aggressive form of skin cancer with rising incidence and morbidity. Despite advances in treatment, the 10-year survival for patients with metastatic disease is less than 10%. During the past few years, ongoing research on different epigenomic aberrations in melanoma has catalyzed better understanding of its pathogenesis and identification of new therapeutics. In our review we will focus on the role of histone variants, key epigenetic players in melanoma initiation and progression. Specifically, incorporation of histone variants enables additional layers of chromatin structure and here we will describe how alterations in this epigenetic behavior impact melanoma.
This article is protected by copyright. All rights reserved.
from #ORL-AlexandrosSfakianakis via simeraentaxei on Inoreader http://ift.tt/1PTvt0t
via IFTTT
from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1KFqO3j
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου